TSPO and colorectal carcinoma: Interfering with TSPO expression has been shown to inhibit CRC cell proliferation and promote apoptosis; for instance, remimazolam (Rem) reduces TSPO levels, decreasing cell viability and proliferation while increasing apoptosis in CRC cells [20].